2020 American Transplant Congress » Poster Session C: Biomarkers, Immune Assessment and Clinical Outcomes

3:30pm-4:00pm

Acute on Chronic Liver Failure (ACLF) Patients Have a Dynamic and Progressive Clinical Course Until Receiving a Liver Transplant: A 5-Year Study at the National Institute of Medical Sciences and Nutrition Salvador Zubiran, Mexico

E. Cervantes-Alvarez¹, M. J. Lizardo-Thiebaud¹, E. Alatorre-Arenas¹, O. Mendez-Guerrero¹, S. Yarza-Regalado¹, A. Torre¹, M. Vilatobá², D. Kershenobich¹, C. A. Huang³, N. Navarro-Alvarez¹

3:30pm-4:00pm

Assessing Providers’ Accuracy in Predicting Early Readmission after Kidney and Liver Transplantation

K. Maroney, Z. Wang, R. Lynch, A. Adams, R. Patzer, J. Hogan

3:30pm-4:00pm

Avoiding Surveillance Biopsy: How? When? Now!

A. Ang¹, C. Schieve², S. Rose², C. Kew¹, M. R. First², R. B. Mannon¹

3:30pm-4:00pm

Calibration of Donor-Derived Cell-Free DNA Criteria for Rejection with Molecular Diagnoses of Kidney Transplant Biopsies

I. Moinuddin¹, D. Kumar¹, L. Kamal¹, A. King¹, L. Kang¹, M. Levy¹, S. Bobba¹, D. Massey¹, P. Halloran², G. Gupta¹

3:30pm-4:00pm

Clinical Correlations Associated with Development of De Novo Donor-Specific Antibody in the First Year Following Kidney Transplant at a Single Center

J. M. Zimmerer¹, M. Basinger¹, B. A. Ringwald¹, R. Pelletier², A. Rajab¹, A. El-Hinnawi¹, M. Abdel-Rasoul¹, K. Washburn¹, G. L. Bumgardner¹

3:30pm-4:00pm

Clinical Performance of a Donor-Derived Cell-Free DNA Assay for Detection of Rejection in Kidney Transplant Recipients

S. Kleiboeker, J. Grantham, K. Mickey, S. Cowden, E. Bixler, R. Sinha, M. Altrich

3:30pm-4:00pm

Combining New Biomarkers: Donor Derived Cell Free DNA (dd-cfDNA) and Transcriptomics Impacts Rejection Diagnosis, Treatment and Follow Up

S. Anand, L. Dong, D. Miller, I. Lloyd, D. Morris, T. Srinivas

3:30pm-4:00pm

Determination of Programmed Cell Death Protein 1 (PD1) by Flow Cytometry, a Possible Follow-Up Tool in Renal Transplantation of High Immune Risk

M. Carmona-Escamilla¹, M. Fonseca², J. Prieto Chávez³, L. Arriaga⁴, F. Oviendo⁵, S. , Hernández-Mendoza SA², J. Alberu⁶, G. Queipo²

3:30pm-4:00pm

Donor-Derived Cell-Free DNA for Detection of Cell-Mediated Rejection in Low Risk Kidney Transplant Patients

S. Anand, L. Dong, M. Fife, J. Krong, S. Dow, D. Morris, T. Srinivas

3:30pm-4:00pm

Galectin-3 as a Biomarker of Disease Severity in Acute-on-Chronic Liver Failure

E. Cervantes-Alvarez¹, F. Tejeda-Dominguez², M. Lizardo-Thiebaud², E. Alatorre-Arenas³, O. Méndez-Guerrero¹, S. Yarza-Regalado¹, D. Kershenobich¹, A. Torre¹, M. Vilatobá⁴, C. A. Huang⁵, N. Navarro-Alvarez¹

3:30pm-4:00pm

Impact of Kidney Transplant Type and Previous Transplant on Baseline Donor-Derived Cell Free DNA

K. K. Sureshkumar, B. Chopra

3:30pm-4:00pm

Pattern of Renal Allograft Injury in Recipients with Normal Donor-Derived Cell-Free DNA

W. Xie, N. Goussous, A. Haririan, M. Weir, J. Bromberg

3:30pm-4:00pm

RNA Sequencing of Urine RNA Samples for Biomarker Discovery

K. S. Keslar¹, D. Margeta¹, M. Abecassis², J. J. Friedewald², P. S. Heeger³, R. L. Fairchild¹

3:30pm-4:00pm

T Cell Hyporesponsiveness in Kidney Transplant Recipients is Associated with Urinary Tract Infections and Age of Kidney Transplant: Implications for Allograft Nephropathy

A. Assounga, S. Omarjee

3:30pm-4:00pm

Urine Donor Derived Cell Free DNA Aids in the Diagnosis of BK Polyomavirus Nephropathy in Kidney Transplant Recipients with BK Viruria

G. Huang¹, X. Chen¹, W. Chen¹, P. Chen¹, T. Jiang², C. Wang¹, L. Chen¹